Review of Long-term efficacy of gliflozins versus gliptins for Type 2 Diabetes after metformin failure: a systematic review and network meta-analysis

The reviewer has opted to publicly display this review, but Plos One's privacy policy prevents this.

Pre-publication Review of

Long-term efficacy of gliflozins versus gliptins for Type 2 Diabetes after metformin failure: a systematic review and network meta-analysis

This review was rated excellent by a journal editor.

Reviewed On March 10, 2019

Submitted to

Reviewed by

Actions

Reviewed on March 10, 2019

Source

References

Wilberto, Z. R., Dobbins, A. R. C., Pinheiro, d. S. F., Correa, B. R. 2020. Long-term efficacy of gliflozins versus gliptins for Type 2 Diabetes after metformin failure: a systematic review and network meta-analysis. Revista da Associacao Medica Brasileira.